Immunogenicity 13205
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CRELD2
Transcript ID
uc031ryb.1
HLA INFO
C*06:02
TCR INFO
No TCR info found!
Full length protein sequence (224 aa)
MATAA
1
EMGAD
6
RATGP
11
AGATW
16
GTRAR
21
CALTA
26
WTATS
31
ARSGT
36
RPTAS
41
AQENS
46
ECLGR
51
ECVVG
56
RQPLG
61
YSGQT
66
DPWID
71
SQDRP
76
LRFLR
81
PSAVR
86
TGLSD
91
SYPPC
96
CLSLG
101
CWRGV
106
GHAWI
111
RGRNT
116
HTQPG
121
YSSRV
126
WIAAF
131
SPACD
136
ESCKT
141
CSGLT
146
NRDCG
151
ECEVG
156
WVLDE
161
GACVD
166
VDECA
171
AEPPP
176
CSAAQ
181
FCKNA
186
NGSYT
191
CEGGP
196
GGRVC
201
TPGPA
206
GFRCC
211
LCQHS
216
FMAS
221
Mutation Information
DNA mutation:
None
Peptide Range:
73 ~ 97
Mut AA position:
85 (13 in Wild Type peptide)
Alignment
Wild Type:
"WIDSQDRPLRFLRPSAVRTGLSDSY
||||||||||||.||||||||||||
Mutant:
WIDSQDRPLRFLPPSAVRTGLSDSY"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CRELD2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay